Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)

NCT05776914 is registered in ClinicalTrials.gov with Madhusudan (Madhu) Grover, MBBS as lead sponsor.

NCT NCT05776914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05776914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)
Lead sponsor
Madhusudan (Madhu) Grover, MBBS
Phase
Phase 2
Overall status
Recruiting
Start date
April 15, 2024
Completion date
June 26, 2027
Enrollment
43 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea, irritable bowel syndrome